ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
US Tech 100
18,208.00
0.46%
Dow Jones
38,711.29
0.36%
Brent Oil
77.445
0.43%
Bitcoin
70,992.79
0.52%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/05/20241:30AMAlliance NewsAlliance NewsGET READY: B&M European Value Retail, Paragon, WH Smith at 0700 BST
06/05/20241:30AMAlliance NewsAlliance NewsAlliance News UK - start of day
06/05/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal TransplantTG:6OPOSE Immunotherapeutics
06/05/20241:30AMGlobeNewswire Inc.OSE Immuno et le Centre Hospitalier Universitaire de Nantes présentent une analyse positive de l’essai clinique de Phase 1/2 évaluant l’immunothérapie FR104/VEL-101 en transplantation rénaleTG:6OPOSE Immunotherapeutics
06/05/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal TransplantLSE:0RADOse Immunotherapeutics Sa
06/05/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal TransplantEU:OSEOSE Immunotherapeutics
06/05/20241:30AMGlobeNewswire Inc.Flash News: OKX Wallet Now Integrated with LazyOtter
06/05/20241:30AMGlobeNewswire Inc.OSE Immuno et le Centre Hospitalier Universitaire de Nantes présentent une analyse positive de l’essai clinique de Phase 1/2 évaluant l’immunothérapie FR104/VEL-101 en transplantation rénaleEU:OSEOSE Immunotherapeutics
06/05/20241:30AMGlobeNewswire Inc.OSE Immuno et le Centre Hospitalier Universitaire de Nantes présentent une analyse positive de l’essai clinique de Phase 1/2 évaluant l’immunothérapie FR104/VEL-101 en transplantation rénaleLSE:0RADOse Immunotherapeutics Sa
06/05/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal TransplantEU:OSEOSE Immunotherapeutics
06/05/20241:30AMGlobeNewswire Inc.KPN and ABP join forces through new TowerCoLSE:31QXKon. Kpn
06/05/20241:30AMGlobeNewswire Inc.KPN and ABP join forces through new TowerCoEU:KPNKoninklijke KPN NV
06/05/20241:30AMGlobeNewswire Inc.KPN and ABP join forces through new TowerCoTG:KPNKoninklijke KPN NV
06/05/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
06/05/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
06/05/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
06/05/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
06/05/20241:30AMGlobeNewswire Inc.Transaction in Own SharesTG:6E2Endeavour Mining Corp
06/05/20241:28AMBusiness WireRocket Lab Successfully Completes Second Launch for NASA Climate Science MissionNASDAQ:RKLBRocket Lab USA Inc
06/05/20241:25AMPR Newswire (US)Nordic Capital to sell Sunrise Medical, one of the globally leading providers of assistive mobility solutions
06/05/20241:08AMPR Newswire (US)XCMG Unveils Revolutionary G2 Series: A New Era of Electric, High-Efficiency Cranes for Global Markets
06/05/20241:05AMPR Newswire (US)PLATINUM EQUITY TO ACQUIRE SUNRISE MEDICAL
06/05/20241:00AMGlobeNewswire Inc.Award-Winning Decision Intelligence Firm Quantexa Accelerates Global Momentum, Announces Strong FY24 Business Results
06/05/20241:00AMGlobeNewswire Inc.Award-Winning Decision Intelligence Firm Quantexa Accelerates Global Momentum, Announces Strong FY24 Business Results
06/05/20241:00AMGlobeNewswire Inc.Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de directionLSE:0OB3Valneva Se
06/05/20241:00AMGlobeNewswire Inc.HENSOLDT, Lufthansa Technik Defense and Bombardier Defense Announce Significant Progress on Global Aircraft Modification for German PEGASUS ProgramHAG
06/05/20241:00AMGlobeNewswire Inc.Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate UpdateVLAP
06/05/20241:00AMGlobeNewswire Inc.Award-Winning Decision Intelligence Firm Quantexa Accelerates Global Momentum, Announces Strong FY24 Business Results
06/05/20241:00AMGlobeNewswire Inc.Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate UpdateTG:AYJValneva SE
06/05/20241:00AMGlobeNewswire Inc.HENSOLDT, Lufthansa Technik Defense and Bombardier Defense Announce Significant Progress on Global Aircraft Modification for German PEGASUS ProgramBBD-B

Your Recent History

NASDAQ
AMRN
Amarin
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
CIVX
CTR Investments and Cons... (CE)
USOTC
WDLF
Decentral Life (PK)
NASDAQ
HOLO
MicroCloud Hologram
NASDAQ
AGBA
AGBA
USOTC
GNCP
GNCC Capital (CE)
NYSE
GME
GameStop
USOTC
IQST
iQSTEL (QX)
USOTC
AXXA
Exxe (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
KGKG
Kona Gold Beverage (PK)
NASDAQ
LWLG
Lightwave Logic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved